Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the safety, tolerability, and efficacy of ST-400 for transfusion-dependent beta-thalassemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transfusion-dependent Beta-thalassemia

Drugs mentioned

• ST-400

Snippet

Sponsor: Sangamo Therapeutics | Conditions: Transfusion Dependent Beta-thalassemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-13